Ian Ying Woo, NovaBridge Biosciences option exercise

Director, SEC Form 4, filed on October 19, 2026
+13,271 sharesnet change in holding. Not an open-market purchase or sale
Transaction date
October 15, 2026
Shares held after
13,271Direct ownership
Change in holding
Could not be calculatedFrom the transactions in the filing
Filing rows
1None is a purchase or sale

Price context

NBP daily close, Apr 27 to October 26, 2026
$2.47$1.22
Daily close
Grants, options, tax
Transaction price
Not reportedNot an open-market trade
Close on trade date
$1.29October 15, 2026
Latest close
$1.22October 26, 2026
Since the trade
−5.81%vs the close on trade date

Transactions in the filing

DateTransactionSecuritySharesPriceAmountAfter
Option exercise
Common stockDirect
13,271
13,271

Recent filings at NovaBridge Biosciences

Full history
PersonTransactionAmount or sharesDate
Phillip Andrew DennisChief medical officer
SaleOption exercise
$5,828
Sean Wuxiong CaoOfficer
Sale
$79,904
Sean Wuxiong CaoOfficer
Option exercise
+339,372 shares
Cong Claire XuVice president
SaleOption exercise
$2,593
Robert A. LenzDirector
Option exercise
+17,218 shares
Cong Claire XuVice president
SaleOption exercise
$3,992